acetyl-l-carnitine nct clinical trials als 500 mg Retrospective observational study on the
Description
If a deficiency is confirmed, B12 injections may be prescribed as part of your treatment plan

An immunoconjugate comprising an antibody according to any one of claims 1-22 attached to an effector wherein said effector is selected from the group consisting of a second antibody, a detectable label, a cytotoxin or cytostatic agent, a liposome containing a drug, a radionuclide, a drug, a prodrug, an immune modulator, a viral particle, a cytokine, a second antibody, and a chelate

By targeting the same or distinct biological pathways, these approaches can increase the pharmacodynamic effect while lowering the risk of drug resistance

H., Goldstein, I., Kim, N

Reported Side Effects (Typically Rare and Mild) Temporary lethargy or slight fatigue

R.ZampeseE.WongY
